GlassScriptPhysician profile
Hayder J Ahmed
NPI 1588927222
$889.23
in general payments reported to CMS, 2019-2025
17 companies · $39.44 in 2025
The $39.44 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.26 · 2020: $139 · 2021: $154 · 2022: $279 · 2023: $111 · 2024: $141 · 2025: $39.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $291.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $167.48 | 2020-2025 | Obsidio |
| Janssen Pharmaceuticals, INC | $115.04 | 2021-2024 | Xarelto |
| Amgen INC. | $94.66 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $92.23 | 2021-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $57.26 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $51.23 | 2022-2023 | Eliquis |
| Heartflow, INC. | $46.73 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $40.51 | 2020-2024 | Andexxa |
| Bardy Diagnostics, INC. | $36.70 | 2020-2022 | |
| Baxter Healthcare | $35.56 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $31.42 | 2021-2024 | Lifevest |
| Abbott Laboratories | $21.99 | 2022 | |
| Astellas Pharma US INC | $21.71 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.66 | 2022 | |
| Z-Medica, LLC | $19.89 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultragenyx Pharmaceutical INC. | $18.83 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.33 | 2024 | Ofev |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hayder Ahmed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.